This first comprehensive systematic synthesis of international NPC guidelines provides a practical reference for clinicians to understand all recommendations and select optimal options based on local resources and expertise while identifying current controversies that demand future research for further standardization and harmonization.
Abstract
Increasing numbers of clinical practice guidelines have been published by international/national groups for nasopharyngeal carcinoma (NPC), providing valuable references for clinicians in making evidence‐based decisions on treatment. However, there are substantial discrepancies in various recommendations, leading to uncertainties in choosing the optimal strategies. The authors systematically searched databases and organizational websites for NPC guidelines published between January 2000 and November 2025. All identified guidelines underwent quality appraisal; in total, 26 clinical practice guidelines rated recommended for use were included. The recommendations covering all management aspects (diagnosis, staging, radiotherapy, systemic therapy, follow‐up surveillance, biomarkers, and salvage of recurrent/metastatic diseases) were summarized and comparatively analyzed for consistency and disparities. Strong consensus exists for diagnostic workup, staging systems, and induction chemotherapy plus concurrent chemoradiotherapy for advanced disease, whereas marked disparities exist on radiotherapy details, particularly target volume delineation, elective coverage extent, and dose specifications. Although systemic therapy strategies for different stage groups were mostly consistent, substantial disparities exist in alternative options and treatment details. This first comprehensive systematic synthesis of international NPC guidelines provides a practical reference for clinicians to understand all recommendations and select optimal options based on local resources and expertise while identifying current controversies that demand future research for further standardization and harmonization.
Hepatoblastoma (HB) is the most common primary liver malignancy in children, predominantly affecting those younger than 3 years of age. Although the overall survival rate has improved significantly over the past few decades, standardized clinical practice guidelines for HB in Korea have been lacking. This clinical prac...
J. Suh, Jisun Hwang, Hee Mang Yoon et al.· Clinical and experimental pe...· 0 citations
As imaging, motion management, adaptive strategies, and functional liver assessment continue to evolve, EBRT can be tailored safely to patients with compromised liver reserve, macrovascular invasion, macrovascular invasion, or transplant pathways.
T. K. Yanagihara, L. A. Dawson, H. Makishima et al.· Practical Radiation Oncology· 0 citations
Over the past decade, cervical cancer management has evolved substantially, with major changes in surgical approach, surgical radicality, nodal staging, imaging, radiotherapy techniques, brachytherapy and systemic treatments. To harmonize practice and integrate new evidence into clinically applicable recommendations, t...
Xavier Carcopino, L. Ouldamer, Cyrille Huchon et al.· Journal of Gynecology Obstet...· 0 citations
Patients with de novo metastatic nasopharyngeal carcinoma were historically deemed incurable and treated with palliative intent. Emergence of potent systemic therapy in combination with local treatment for both locoregional and metastatic diseases has enabled long-term survival in some patients. This international guid...
Qiao-Juan Guo, Qin Liu, P. Bossi et al.· The Lancet Oncology· 0 citations
The Advanced Breast Cancer (ABC) 8th international consensus conference took place on 6-8 November 2025, in Lisbon, and updated the previous ABC international consensus guidelines that are described in this manuscript. These guidelines reflect the work of a large and global consensus panel, comprising healthcare profes...
F. Cardoso, J. Ribeiro, E. Schumacher-Wulf et al.· Breast· 0 citations
Precision oncology in biliary tract cancers (BTCs) requires more than identifying actionable biomarkers: clinical practice guidelines must connect who and how to test with the treatment or trial action that follows a positive result. We systematically evaluated contemporary BTC guidelines for methodological quali...
Xi-Xiang Pan, Qing An, Jian-Ting Liu et al.· BMC Cancer· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.